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Abstract
Collagen XIII is a conserved transmembrane collagen mainly expressed in mesenchymal tissues. Previously, we have shown 
that collagen XIII modulates tissue development and homeostasis. Integrins are a family of receptors that mediate signals 
from the environment into the cells and vice versa. Integrin α11β1 is a collagen receptor known to recognize the GFOGER 
(O=hydroxyproline) sequence in collagens. Interestingly, collagen XIII and integrin α11β1 both have a role in the regulation 
of bone homeostasis. To study whether α11β1 is a receptor for collagen XIII, we utilized C2C12 cells transfected to express 
α11β1 as their only collagen receptor. The interaction between collagen XIII and integrin α11β1 was also confirmed by sur-
face plasmon resonance and pull-down assays. We discovered that integrin α11β1 mediates cell adhesion to two collagenous 
motifs, namely GPKGER and GF(S)QGEK, that were shown to act as the recognition sites for the integrin α11-I domain. 
Furthermore, we studied the in vivo significance of the α11β1-collagen XIII interaction by crossbreeding α11 null mice 
(Itga11−/−) with mice overexpressing Col13a1 (Col13a1oe). When we evaluated the bone morphology by microcomputed 
tomography, Col13a1oe mice had a drastic bone overgrowth followed by severe osteoporosis, whereas the double mutant 
mouse line showed a much milder bone phenotype. To conclude, our data identifies integrin α11β1 as a new collagen XIII 
receptor and demonstrates that this ligand-receptor pair has a role in the maintenance of bone homeostasis.
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Introduction
The adhesion of cells to the neighboring cells and to the 
extracellular matrix (ECM) is critical for their survival, 
migration, differentiation, and signal transduction. Integrins 
are an important family of molecules involved in cell-ECM 
adhesion process. They are heterodimeric membrane gly-
coproteins consisting of non-covalently associated α and β 
subunits (Pandolfi et al. 2017; Barczyk et al. 2010). The 
ligand-binding specificity of most integrins is well known 
(Pandolfi et al. 2017; Barczyk et al. 2010). Four collagen-
binding integrins, α1β1, α2β1, α10β1, and α11β1, are 
expressed in various tissues (Hemler et al. 1986; Camper 
et al. 1998; Gullberg et al. 1995). The collagen receptor 
integrin α subunits are characterized by an inserted domain 
named as the I domain (often called as the A domain) that 
mediates interaction with native collagens (Hamaia and 
Farndale 2014; Zeltz and Gullberg 2016).
Collagen XIII is a type II transmembrane protein com-
posed of a short cytosolic head, a transmembrane anchor, 
and a long extracellular domain with three collagenous 
domains (COL1-3) and four non-collagenous domains 
(NC1–4) (Hägg et al. 1998; Heikkinen et al. 2012). Our 
previous in vitro studies using solid-phase assays showed 
that the I domain of the integrin α1 subunit binds to collagen 
XIII with similar approximated avidity as to collagen IV 
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(Nykvist et al. 2000), but the binding site in the collagen was 
not characterized. In another report, we suggested that col-
lagen XIII mediates integrin α1β1-dependent transmigration 
of monocytes in renal fibrosis with a binding site different 
from other integrin I domain binding motifs (Dennis et al. 
2010). These data prompted us to investigate the binding of 
collagen XIII to other collagen receptor integrins.
Collagen XIII is broadly distributed in mesenchymal 
tissues at low levels (Hägg et al. 2001; Sund et al. 2001; 
Sandberg et al. 1989; Juvonen et al. 1992; Sandberg-Lall 
et al. 2000). Many studies with genetically modified mice 
have indicated its physiological functions in musculoskel-
etal tissues (Ylönen et al. 2005; Härönen et al. 2017, 2019; 
Zainul et al. 2018; Koivunen et al. 2019) and congenital 
myasthenic syndrome type 19 (CMS19; OMIM #616,720) 
musculoskeletal phenotypes (Logan et al. 2015; Rodriguez 
Cruz et al. 2019).
Integrin α11β1 is a collagen receptor (Lu et al. 2010) 
recognizing the GFOGER (O=hydroxyproline) sequence in 
interstitial collagens (W. M. Zhang et al. 2003). We consider 
of interest that both collagen XIII and integrin α11β1 are 
induced in several tumor tissues (Väisänen et al. 2005, H. 
Zhang et al. 2018, Izzi et al. 2019, Mirtti et al. 2006, Zhu 
et al. 2007, Primac et al. 2019) and that they are involved 
in the regulation of bone development and homeostasis 
(Blumbach et al. 2012; Shen et al. 2019; Ylönen et al. 2005; 
Koivunen et al. 2019). Therefore, we chose to analyze the 
interaction between these two molecules. We found that 
α11β1 mediates cell spreading on a collagen XIII-coated 
surface and that two collagenous motifs, GPKGER and 
GF(S)QGEK, in the collagen XIII ectodomain contribute 
in the in vitro binding to the integrin α11-I domain. Addi-
tionally, we show that collagen XIII-integrin α11 interaction 
participates in the maintenance of bone homeostasis in vivo.
Materials and methods
Cells
Murine C2C12 myoblast cells from the American Type 
Culture Collection (ATCC) were stably transfected with a 
human integrin α2 cDNA or a human integrin α11 cDNA 
(Tiger et al. 2001), the cDNA encoding the integrin α11 
was tagged with enhanced green fluorescent protein (EGFP) 
C-terminally (Erusappan et al. 2019). Mouse embryonic 
fibroblast cells (MEFs) were isolated from wild-type mouse 
embryos as described previously (Popova et al. 2004, 2007) 
and cultured at 37 °C in DMEM (Biochrom AG, Berlin, Ger-
many) supplemented with 10% FCS (Euroclone, UK) and 
antibiotics (Cambrex, USA). Immortalized cell lines were 
created by induction of simian virus 40 (SV40) as described 
previously (Barczyk et al. 2013).
Production of integrin I domains
The recombinant I domains of the human integrins α1 and 
α2 were produced as described previously (Nykvist et al. 
2000). Briefly, the α1-I domain cDNA was generated by 
PCR using a human integrin α1 cDNA (Briesewitz et al. 
1993) as a template, cloned into the pGEX-4T-3 vector 
with a GST tag (GE Healthcare, USA), and the protein 
was expressed in E. coli. The α2-I domain cDNA was pro-
duced by PCR using a human integrin α2 cDNA (Takada 
and Hemler 1989) as a template, cloned into the pGEX-2T 
vector (GE Healthcare, USA) and the GST- α2I fusion pro-
tein was expressed in E. coli. The α11-I domain cDNA was 
generated similarly by PCR using a human integrin α11 
cDNA (Velling et al. 1999) as a template, and then cloned 
into the pAcSecG2T vector (Invitrogen, USA). The α11-I 
domain was expressed as a GST-tagged fusion protein and 
secreted into cell culture media in insect High-Five cells 
(Invitrogen) using a Baculovirus expression system (Invit-
rogen). All recombinant GST-I domains were purified using 
glutathione-Sepharose affinity chromatography (GE Health-
care) and their purities were analyzed by SDS-PAGE.
Production of the recombinant human collagen 
XIII ectodomain, its collagenous peptides 
and triple‑helical motifs
The ectodomain of human collagen XIII was produced as 
described previously (Tu et al. 2002). High Five insect cells 
(Invitrogen) were cultured in a monolayer and co-infected 
with a virus encoding the human collagen XIII α1 chain 
lacking the cytosolic domain (Snellman et al. 2000) and 
another virus encoding both the α and β subunits of human 
prolyl 4-hydroxylase (Lamberg et al. 1996; Nokelainen et al. 
1998). The ectodomain was purified from ~ 400 ml of 48-h 
infected culture media sequentially using a HiTrap™ Q 5 ml 
column (GE Healthcare), a HiTrap™ SP 5 ml column (GE 
Healthcare), and a HiLoad™ Superdex™ 200 column (GE 
Healthcare). Its purity was analyzed by native gel electro-
phoresis and SDS-PAGE.
The collagenous peptides of collagen XIII were produced 
by enzymatic digestion of 400 μg of the collagen XIII ecto-
domain with 0.4 μg of pepsin at pH 2–3 for 30 min at room 
temperature and then isolated by a Superdex-200 column 
in 20 mM HEPES buffer, pH 7.0, containing 0.3 M NaCl.
The recombinant proteins composing the testingmotifs 
were produced in E. coli or insect cells. The DNA frag-
mentencoding (GPP)5GFPGER(GPP)5 was produced by 
atwo-step PCR reaction. In the first step, the template for the 
reaction 1 was formed fromannealing of two synthetic oligo-
nucleotides 5′-GCC ATG GCT GGA CCC CCC GGC CCT CCT 
GGA CCT CCT GGT CCC CCT GGT CC-3′ and 5′-TGG TCC 
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CGG TGG ACC ACG CTC GCC AGG GAA ACC GGG AGG ACC 
AGG GGG ACC -3′. The only primer 5′-ACA AGG CCA TGG 
CTG GAC CCCCC-3′was used for forward extension. The 
template for the reaction 2 was fromannealing of another 
pair of oligos 5′-ACC GGA TCC CGG TGG GCC AGG TGG 
TCC GGG TGG ACC CGG TGG TCC CGG TGG ACC -3′ and 
5′-GGT CCC CCT GGT CCT CCC GGT TTC CCT GGC GAG 
CGT GGT CCA CCG GGA CCA-3′ and a primer 5′-GTA ACC 
GGA TCC CGG TGG GCC AGG T-3′ for the reverse extension. 
After fivecycles, the two reaction products were mixed and 
25 more PCR cycles continued.
The cloning of other motifs followed the same strategy 
except changes in two oligonucleotides for annealing, one 
in italic and underlined, and another in bold and underlined.
The final PCR products were digested with NcoI and 
BamHI, and the purified DNA was inserted into a plasmid 
 pHisTRX2-Foldon (a gift kindly from J. Engel). The DNA 
sequence was confirmed by DNA sequencing. The DNAs 
encoding (GPP)5motif(GPP)5-foldon were further cloned by 
PCR using primers containing KpnI and HindIII cleavage 
sites (forward primer AGCTC GGT ACC AGG ACC CCC CGG 
CCCT; reverse primer CTA ATT AAG CTT TTA CAG GAA 
GGT AGA), and the enzymatic digested PCR products were 
inserted into a plasmid pQE3.1 (Qiagen) for expressing the 
recombinant protein composing 6xHis-(GPP)5motif(GPP)5-
foldon in an E. coli strain BL21(DE3). To express the fusion 
proteins in insect cells, the DNA fragments were cloned by 
PCR using a forward primer TCT GCA GCG GCC GCATG 
AGA GGA TCT CAC CAT and a reverse primer CTT CTA 
GAA TTC TTA TTA CAG GAA GGT AGA and then inserted 
to the expression vector pVL1392 (Invitrogen) through 
the NotI and EcoRI cleavage. The recombinant fusion pro-
teins were produced from the cell lysates by His-tag affinity 
purification using Ni-NTA resin (Qiagen). The peptide trim-
erization was confirmed by a gel filtration chromatography.
Cell attachment assay
The cells attached to the culture plates were monitored 
directly by microscopy or quantitatively analyzed using 
a β-hexosaminidase release assay (Landegren 1984). The 
ligands used for the cell attachment assays were human 
plasma fibronectin (Invitrogen), rat tail collagen I (Col-
laborative Biomedical Products, USA), collagen XIII ecto-
domain, and its motif-foldon fusion proteins, at a concen-
tration of 10 μg/ml in PBS or in 20 mM HEPES, 0.15 M 
NaCl, pH 7.0, 0.2% heat-inactivated BSA (crystallized, 
Serva, Germany) in PBS was used as a blank control. The 
24-well cell culture plates (Greiner Bio-one, Germany) 
were coated with 300 μl of the ligands at 4 °C overnight. 
The plates were rinsed 3 times in PBS, and the uncoated 
surface was then blocked with 0.2% heat-inactivated BSA 
in PBS at 37 °C for 1 h and washed with Puck’s saline 
(137  mM NaCl, 5  mM KCl, 4  mM  NaHCO3, 5.5  mM 
D-glucose, and 2 mg/L phenol red equilibrated with 5% 
 CO2 at 37 °C) containing 2 mM  MgCl2 and 20 µM  CaCl2. 
For the attachment testing, C2C12 cells at 60–80% con-
fluence were detached by trypsin-EDTA treatment and 
washed once with DMEM containing FCS to inactivate the 
trypsin and then 3 times with Puck’s saline. The cells were 
added to the wells at a density of 100,000 cells/0.5 ml/well. 
They were allowed to attach for 1 h at 37 °C in Puck’s 
saline, and non-attached cells were removed by washing for 
3 times with Puck’s saline. For the β-hexosaminidase assay, 
the attached cells were lysed for 2 h at 37 °C in 200 μl 
0.05 M citrate, pH 5.0, containing 0.25% Triton X-100 
and 3.75 mM p-nitrophenyl-N-acetyl-β-D-glucosaminide 
(Sigma, USA). Fifty microliters of the cell lysates were 
loaded onto a 96-well microtiter plate (Nunc, Denmark) 
and the reaction was stopped, and color developed by add-
ing 75 μl of 45 mM glycine solution, pH 10.4, containing 
4.5 mM EDTA. The absorbance at 405 nm was measured 
using a Victor microplate reader (Perkin Elmer, USA). 
A cell number calibration curve was made by incubating 
known numbers of cells under equivalent conditions. Three 
repeated experiments were performed in the tests. The data 
were normalized by taking adhesion to a fibronectin-coated 
surface as 100% cell attachment and that to wells coated 
with BSA only as 0%. In the inhibition assay, motif-fusion 
proteins, with the molar ratios of 1:1, 5:1, and 10:1 to the 
coating collagen XIII, were mixed with the cells first and 
then added to the collagen XIII-coated plate wells.
Immunofluorescence staining and EGFP imaging
The glass coverslips were coated and blocked in the same 
way as for the 24-well plates in the cell attachment assay. The 
cells were allowed to adhere at a density of 9000 cells/30 µl/
coverslip in DMEM containing 10% FCS or in serum-free 
DMEM for 1.5–2 h at 37 °C complemented with 5%  CO2. 
After washing the coverslips with PBS, the attached cells 
were fixed in acetone at − 20 °C for 8 min or in 4% PFA 
at room temperature for 10 min and then permeabilized in 
acetone at − 20 °C for 5 min. Non-specific binding sites 
were blocked by incubating with 10% goat serum (Zymed 
Laboratories, Inc., USA) diluted in PBS. The fixed cells 
were incubated with the antibody against integrin α11 cyto-
plasmic domain (Popova et al. 2004) for 1–2 h at 37 °C or 
at 4 °C overnight. Cy2-, Cy3- (Jackson ImmunoResearch 
Laboratories, USA), Alexa Fluor 488-, and Alexa Fluor 
568-conjugated secondary antibodies (Invitrogen) were used 
for detection. The stained cells were mounted in Immu-
Mount mounting solution (Thermo Shandon, USA), visu-
alized and photographed under a Leitz Aristoplan micro-
scope (Leica Microsystems, Germany) or an Olympus BX51 
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(Olympus, Japan) equipped with optics for observing fluo-
rescence. To visualize C2C12-α11 + , cells were fixed in 2% 
PFA + 0.1% Triton X-100 and mounted as described above.
Western blotting
To verify the expression of integrin α11, C2C12 cells in 
one culture plate (Φ = 100 mm) at 80–90% confluence were 
washed once with 10 ml of PBS and then detached with a 
cell scraper into 1 ml of PBS. The cells were harvested by 
centrifuging at 340×g for 10 min and then homogenized 
for 1 min with 0.5 ml of 70 mM Tris/0.3 M NaCl/0.2% 
Triton X-100, pH 7.4, containing Protease Inhibitor cocktail 
(Roche Applied Science, Germany), followed by incubation 
on ice for 30 min. After centrifuging at 8000×g for 10 min, 
the supernatant of the cell lysate was applied to SDS-PAGE 
followed by western blotting. The expression of recombinant 
human integrin α11 in C2C12 cells was detected with an 
affinity-purified antibody against the human α11 cytoplas-
mic domain (Tiger et al. 2001).
Solid‑phase binding and surface plasmon resonance 
assays
Fifty microliters of collagen solutions, collagen I (Collabo-
rative Biomedical Products, USA), collagen IV (BD Bio-
sciences), collagen XIII ectodomain, its pepsin-digested 
fragments, and the recombinant motif-fusion proteins, 
were coated on the plastic surfaces of MaxiSorp™ 96-well 
microplates (Nunc) at 4 °C overnight. All the other steps 
were performed at room temperature using a buffer contain-
ing 20 mM Tris, 0.15 M NaCl, 2 mM  MgCl2, 20 µM  CaCl2, 
0.05% Tween-20, or 10 mM HEPES, 0.15 M NaCl, 2 mM 
 MgCl2, 20 µM CaCl2, pH 7.0. Three parallel samples were 
analyzed. The wells were blocked with 5% fat-free milk in 
Tris buffer or in HEPES buffer for 1 h and the samples incu-
bated for 1.5 h with α1-, α2-, and α11-I domains diluted in 
the buffer containing 30 μg/ml BSA (crystallized, Serva). 
After thorough washing, the binding ligands were detected 
with a goat polyclonal anti-GST antibody (Rockland Immu-
nochemicals, USA) and then with an anti-goat IgG second-
ary antibody conjugated with horseradish peroxidase (Dako, 
Denmark). TMB-Xtra (Kem-En-Tec Diagnostics A/S, Den-
mark) was used as the substrate for detection.
Surface plasmon resonance (SPR) analysis was per-
formed at 25 °C in a BIAcore® 3000 system (Biacore AB, 
Sweden) using a CM5 sensor chip (Biacore). Integrin α11-I 
domain was immobilized onto the chip at a level of 2000 
resonance units (RUs). Binding of collagen XIII was tested 
in 10 mM HEPES, pH 7.0, 0.15 M NaCl, 2 mM  MgCl2, 
20 μM  CaCl2 containing 0.005% P-20 surfactant (Biacore) at 
a flow rate of 20 μl/min. The blank   was carried out on one 
of the flow cells on the sensor chip lacking the immobilized 
I domain protein.
Pull‑down assay
Insect High-Five cells were infected with viruses encoding 
GST and GST-α11-I domain respectively with MOI of 10 
in TNM-FH media (Sigma) containing 10% FCS. Eighty 
percent of the recombinant proteins were secreted into the 
media due to a signaling peptide in the expression vector. 
Forty-eight postinfection 5 ml media from each cell culture 
plate were collected and dialyzed in PBS containing 0.1 mM 
DTT and 0.001% Triton. The media were then mixed with 
the glutathione-Sepharose pre-equilibrated with the dialysis 
buffer at 4 °C overnight. After washing out the unbound 
proteins, the purified collagen XIII ectodomain was incu-
bated with the Sepharose resin in 10 mM HEPES, pH 7.0, 
containing 0.15 M NaCl and 2 mM  MgCl2 at room tem-
perature for 2 h. The unbound collagen XIII was removed 
by extensive washing steps and the proteins absorbed on 
the glutathione-Sepharose were eluted by incubating with 
either 10 mM glutathione or one cleavage unit of thrombin 
at room temperature overnight. The unbound collagen XIII 
was incubated at room temperature overnight as a control. 
The elution fractions were analyzed with a western blotting 
using a monoclonal antibody recognizing the recombinant 
human collagen XIII (Tu et al. 2002).
Sequence retrieval and alignment
The full-length human integrin α11 sequence is 1188 res-
idues in length. We retrieved only the I domain residues 
ranging from 164 to 345 which comprises 182 residues in 
total (later renumbered from 1 to 182) from the UniProtKB 
(Q9UKX5). The crystal structure of the human integrin α2-I 
domain bound with the collagen peptide (PDB code: 1DZI) 
as well as the sequence information was obtained from the 
PDB (Berman et al. 2000). Sequence alignment between 
the integrin domains of α2 and α11 was carried out using 
ClustalW2 (Larkin et al. 2007) with default settings.
Homology modeling of the human integrin α11‑I 
domain
The final sequence alignment obtained from the 
CLUSTALW2 program was submitted to the MODEL-
LER9v1 software package (Eswar et  al. 2006; Sali and 
Blundell 1993) for constructing the homology model of the 
human integrin α11-I domain. Twenty different models were 
generated and the model with the lowest energy was consid-
ered as the ideal model.
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Energy minimization and structure validation
Energy minimization of the human integrin α11-I domain 
model was carried out using GROMACS version 4.0.7. 
(Hess et al. 2008; Van Der Spoel et al. 2005). Initially, the 
protein was placed in a cubic box and a SPC water model 
was used for solvation. After solvating, suitable ions were 
added to neutralize the whole system. The final system was 
composed of 13,073 molecules, which includes the protein 
(182 residues), water (12,882 molecules), and ions (9  Na+). 
The whole system was then subjected to 1000 steps of steep-
est descent minimization using the GROMOS96 53a6 force 
field until the maximum force converged to < 1000.0 kJ/
mol/nm with PME (Particle Mesh Ewald) as the Coulomb 
type, the rcoulomb cutoff of 1.0 and van der Waals cutoff 
of 1.0. For validation purposes, the minimized final model 
was submitted to various structure validation programs 
(PROCHECK, VERIFY3D and ERRAT) available through 
SAVeS server (https ://servi cesn.mbi.ucla.edu/SAVES /).
Collagen triple‑helical peptide construction
The crystal structure of the α2-I domain-collagen pep-
tide complex was downloaded from the PDB databank, 
and then collagen triple-helical peptides (strands B, C, D) 
were manually separated from the integrin domain. Each 
peptide sequence comprises of 21 amino acid residues (the 
residues in each peptide strands were later renumbered 
from 1 to 21). Here, we constructed three different colla-
gen triple-helical peptides namely, (GPP)2GFQGEK(GPP)3, 
and (GPP)2GPKGER(GPP)3. These collagen triple-helical 
peptides were constructed using COOT software package 
(P. Emsley et al. 2010). All these constructed triple-helical 
peptides were then subjected to 500 steps of steepest descent 
minimization using GROMACS version 4.0.7 (Hess et al. 
2008; Van Der Spoel et al. 2005). The final energy mini-
mized triple-helical peptides were then used for docking 
with the human integrin α11-I domain.
Protein‑protein docking
Docking of modeled human α11-I domain and the con-
structed triple-helical peptides (α11-(GPP)2GFQGEK(GPP)3 
and α11-(GPP)2GPKGER(GPP)3 were carried out using the 
HADDOCK program (Dominguez et al. 2003), a Web-based 
tool to perform protein-protein docking. The HADDOCK 
docking program is driven based on the Ambiguous Interac-
tion Restraints derived from the experimental information 
of the intermolecular interacting residues provided by the 
user. We used the easy interface for all the docking calcula-
tions. However, before carrying out the docking experiments 
between the modeled human α11-I domain and collagen XIII 
peptides, we first performed a control docking experiment 
using the crystal structure of ligand-binding α2-I domain 
to validate the HADDOCK docking program. Upon dock-
ing of α2-I domain and its collagen triple-helical peptide 
(GFOGER), the program had predicted the key interact-
ing residues as seen in the crystal structure suggesting that 
HADDOCK can be used for the docking calculations using 
the triple-helical peptides. The constructed peptides were 
then docked to the modeled α11-I domain. The best rep-
resentative docked complex was chosen based on the low-
est energy cluster and HADDOCK score obtained through 
diverse energy terms such as van der Waals energy, elec-
trostatic energy, desolvation energy, restraints violation 
energy and buried surface area. PDBsum database was used 
to analyze the protein-peptide interactions while the bind-
ing energy (ΔG) was calculated using the PRODIGY server 
(Xue et al. 2016).
Mouse line
Generation of the transgenic Col13a1oe mice has 
been described previously (Ylönen et  al. 2005), and 
the mouse line is publicly available in the Infrafron-
tier EMMA repository with the strain name B6.Cg-
Tg(Col13a1)2Pih/Oulu (EM:09885). Generation of 
Itga11−/− mice has been described previously (Pop-
ova et  al. 2007). Here, Itga11−/− mice in C57BL/6J 
background were bred with Col13a1oe to generate a 
Col13a1oe;Itga11−/− double mutant mouse line, overex-
pressing Col13a1 and lacking Itga11. Col13a1oe littermates 
were used as controls. Permission for the maintenance of 
mice (license ID ESAVI/4220/04.10.07/2013) was obtained 
from the Finnish Animal Care and Use Committee of the 
State Provincial Office of Southern Finland (Hämeenlinna, 
Finland) and the European Community Council Directive on 
the protection of animals used for scientific purposes (Sep-
tember 22, 2010; 2010/63/EEC), national legislation and the 
regulations for the care and use of laboratory animals were 
followed.
µCT
Tubular bone microarchitecture was assessed from left 
femurs of Col13a1oe;Itga11−/− mice, and they were 
compared to Col13a1oe mice. Number of mice analyzed 
in order of increasing age: female Col13a1oe (7, 4, 6, 
6, 6), female Col13a1oe;Itga11−/− (3, 3, 4, 3, 2), male 
Col13a1oe (5, 4, 7, 6), male Col13a1oe;Itga11−/− (3, 3, 3, 
3). The most recent guidelines for bone microstructure 
assessment were used (Bouxsein et al. 2010). Bones were 
imaged using a Skyscan 1176 scanner (Bruker microCT, 
Kontich, Belgium) using the following parameters: X-ray 
tube voltage of 50 kV, current of 500 µA, exposure time 
of 4000 ms, and a 0.5 mm aluminum filter. Projection 
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images were collected every 0.3° over a 360° rotation. 
Image processing was performed with the manufacturer’s 
software NRecon (v. 1.6.5.2), Dataviewer (v. 1.5.6.2), 
and CTAn (v. 1.11.10.0). Femur length was measured 
from reconstructed datasets from the superior top of 
trochanter major to the distal patellofemoral groove in 
mid-frontal plane. The average value of three separate 
measurements was used as the result for the femur length. 
Measurements were conducted using the manufacturer’s 
software (Skyscan, Dataviewer v. 1.5.6.2). Besides the 
femur length, cortical bone morphology was assessed. 
Diaphyseal cortical bone was assessed using the VOI 
starting 0.9  mm distally from the femoral neck and 
extending further distally. Two different ROI lengths 
were used for cortical bone analysis: 3.6 mm was used 
for 4-week time point, whereas 5.4 mm was used for 
other time points. 2D structural analysis was performed 
to define cortical bone area (Ct.Ar) and average corti-
cal thickness (Ct.Th). 2D volumetric analyses of data-
sets were conducted using CTAn software (Skyscan, v. 
1.11.10.0).
Statistics
Statistical significance was determined by two-way 
ANOVA followed by the Benjamini, Krieger, and Yekutieli 
FDR post hoc test (Benjamini et al. 2006). Values of FDR-
corrected p (q) < 0.05 values were considered statistically 
significant. No statistical methods were used to predeter-
mine sample size.
Results
Integrin α11β1 is localized at focal contacts in cells 
spreading on a collagen XIII‑coated surface
To determine whether α11β1 mediates the spreading of 
cells on collagen XIII, α11-EGFP transfected C2C12 
mouse myoblasts (C2C12-α11 +), and mouse embry-
onic fibroblasts (MEFs) derived from a wild-type mouse 
embryo were tested. Direct f luorescence imaging of 
C2C12-α11+ cells showed that α11-EGFP localized at 
cell-matrix adhesion structures during cell spreading on 
collagen XIII (Fig. 1a) and on collagen I (Fig. 1c), but 
not on fibronectin (Fig. 1e). The cellular localization of 
integrin α11β1 on primary MEFs on collagen XIII was 
studied by immunofluorescence staining using an anti-
body against the cytoplasmic domain of the mouse inte-
grin α11 subunit (Fig. 1b). Spreading on collagen I was 
analyzed as a control (Fig. 1d). These data indicate that 
both collagen XIII and collagen I, but not fibronectin, are 
functional ligands for integrin α11β1.
C2C12 cells expressing integrin α11β1 adhere 
to collagen I and collagen XIII‑coated surfaces
The interaction between collagen XIII and integrin α11β1 
was further studied by using the transfected C2C12 cells 
that expressed human α11β1 as their only collagen receptor 
(Tiger et al. 2001). C2C12 cells transfected with the vector 
plasmid (MOCK) were tested in parallel. The expression 
of the α11 subunit was verified by western blotting using 
an antibody specific for the cytoplasmic domain of the 
human integrin α11 (Fig. 1e). C2C12 control cells did not 
adhere to native collagen I or to native collagen XIII, but 
the cells attached well to fibronectin due to the endogenous 
expression of fibronectin receptor integrins (Fig. 2a). Cell 
attachment assays utilizing C2C12 cells that were stably 
transfected with the full-length human integrin α11 cDNA 
(C2C12-α11+ cells) indicated a remarkable increase in 
adhesion to collagens I and XIII when compared to con-
trol C2C12 cells (Fig. 2a). The attached C2C12-α11+ cells 
started to spread on the collagen XIII-coated surfaces after 
2 h (Fig. 2b). For control purposes, C2C12-α2+ cells were 
tested with similar results as in our previously published 
study (Fig. S1), i.e., integrin α2 can mediate cell spreading 
on collagen I but not on collagen XIII (Nykvist et al. 2000). 
Integrin α2β1 and α11β1 have both been suggested to be the 
cellular receptors for fibrillar collagens (Zeltz and Gullberg 
2016), but the present results demonstrate a remarkable dif-
ference in their preference for collagen XIII.
Collagen XIII binds to the I domain of integrin α11 
subunit with high avidity in vitro
A GST-α11 I-fusion protein has previously been produced in 
E. coli (W. M. Zhang et al. 2003), but the protein yield and 
binding activity varied from batch to batch (Käpylä J. et al., 
unpublished). To facilitate studies on the interaction between 
integrin α11β1 and collagen XIII in more detail, we set up an 
expression system of the α11-I domain as a secreted protein 
in insect cells. The recombinant protein contains a GST-
tag and a thrombin cleavage site between GST and the I 
domain. The α11-I domain was purified from the medium 
by a one-step GST-affinity purification method. The unpuri-
fied media containing GST-tagged α11-I domain or GST as 
a blank control was used for binding specificity test in vitro. 
The human collagen XIII ectodomain was expressed as a 
homotrimer using a baculovirus system in insect cells (Tu 
et al. 2002). Furthermore, collagen types I and IV were com-
pared to collagen XIII in the binding assays. The integrin 
α1- and α2-I domains obtained from E. coli (Nykvist et al. 
2000) which also contained the GST-tags, were included 
for selected interaction studies. The binding tests were 
performed using an enzyme-linked immunosorbent assay 
(ELISA) in which collagens I, IV, and XIII were coated onto 
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the plastic surface as solid ligands and the I domains were 
used as soluble analytes. The interaction was detected using 
a GST antibody. The α11-I domain interacted with collagen 
types I and XIII in a dose-dependent manner (Fig. 3a). Col-
lagen XIII was identified to bind α11-I domain with similar 
affinity as collagen I and stronger than collagen IV (Fig. 3b). 
Consistently with the previously published results (W. M. 
Zhang et al. 2003; Tiger et al. 2001; Nykvist et al. 2000), 
collagen IV showed preferential binding to the α1-I domain, 
but no binding to the α11-I domain (Fig. 3b). In contrast to 
collagens IV and XIII, collagen I bound well to all the tested 
integrin I domains (Fig. 3b).
The specific interaction between collagen XIII and inte-
grin α11β1 was further confirmed by surface plasmon reso-
nance (SPR) and pull-down assays. In SPR, collagen XIII 
showed a typical sensorgram of binding to the immobilized 
fusion protein α11-I domain (Fig. 3c, black curve) unlike 
in the blank control in which no protein was immobilized 
(Fig. 3c, gray curve). In a pull-down assay, collagen XIII 
was trapped only by the GST-α11-I domain coupled to the 
glutathione-Sepharose but not when GST was used alone. 
The protein complex could be eluted by glutathione or 
thrombin, indicating that the interaction site locates in the 
α11-I domain (Fig. 3d). Due to the long incubation time at 
room temperature, collagen XIII eluted from the interac-
tion complex was partly degraded, resulting in a reduced 
molecular mass of 60 kDa. The unbound fraction contained 
both this 60 kDa fragment as well as the full-length 72 kDa 
collagen XIII ectodomain, and after overnight incubation, 
mimicking the enzyme digested fractions, equal degradation 
of the unbound fraction was evidenced (Fig. 3d).
Integrin α11‑I domain binds specifically 
to the C‑terminal collagenous domain of collagen 
XIII
To identify the potential integrin α11β1 binding sites in 
collagen XIII, the purified collagen XIII ectodomain was 
digested by pepsin and the cleaved fragments were sepa-
rated by gel-filtration chromatography (Tu et al. 2002). 
The peptide representing the COL3 domain showed simi-
lar integrin-binding capability as the intact ectodomain 
Fig. 1  Localization of integrin 
α11β1 in cells spreading on 
collagens XIII and I. C2C12 
cells transfected with integrin 
α11-EGFP were seeded onto 
coverslips coated with collagen 
XIII (Col XIII) ectodomain 
a and collagen I (Col I) c and 
allowed to adhere at 37 °C for 
2 h. The cells were then fixed 
and imaged on a fluorescence 
microscope with direct detec-
tion of EGFP-tagged protein. 
e The C2C12-α11+ cells 
spreading on the fibronectin-
coated surface. Primary wild 
type MEFs spread on collagen 
XIII b and on collagen I d under 
the same conditions as the 
C2C12-α11+ cells and were 
visualized with indirect immune 
fluorescence staining using an 
antibody against the cytoplas-
mic domain of mouse integrin 
α11. e C2C12 cells were stably 
transfected with integrin α11, 
and the expression of α11 was 
analyzed by western blotting 
using an antibody against the 
α11 cytoplasmic domain
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(Fig. 4a). Collagen XIII does not contain the GFOGER or 
other previously identified integrin-binding motifs (Uni-
Prot Consortium 2019). However, the COL3 domain in 
collagen XIII harbors two GER and seven GEK sequences 
that are typically found as parts of the known integrin-
binding motifs. To test these putative binding sequences, 
two GER motifs, namely GPKGER and GNRGER, and one 
GEK motif, namely GF(S)QGEK (“S” in mouse), were 
expressed in E. coli using an expressing vector encoding 
two (GPP) × 5 sequences flanking the tested fragments, a 
foldon sequence for triple-helical formation (Frank et al. 
2001), and a His-tag for the protein purification (Fig. 4c). 
GFPGER was chosen as a positive control and GEK-
GAKGSPGLP, a peptide located on the COL2 domain 
and binding to integrin α1β1 (Dennis et al. 2010), was 
produced for a negative control. Other GEK motifs were 
considered less interesting based on the knowledge gained 
from the peptide ToolKits of collagen-receptor interac-
tions (Farndale et al. 2008). The motifs GPKGER and 
GF(S)QGEK showed positive binding to the integrin α11-I 
domain, albeit at a 50–60% lower approximated avidity 
when compared to GFPGER (Fig. 4b). GEKGARGSPGLP 
and GNRGER showed no binding (Fig. 4b). The protein-
protein interaction was further confirmed by a cell attach-
ment assay utilizing collagen I, the ectodomain of collagen 
XIII, and the recombinant proteins containing the putative 
integrin-binding motifs. The binding of cells was markedly 
stronger to the GPKGER than to the GF(S)QGEK motif 
(Fig. 4d). Furthermore, the attachment of C2C12-α11+ 
cells to the collagen XIII-coated surface could be partially 
inhibited by GPKGER (Fig. 4e). These data suggested that 
both GPKGER and GF(S)QGEK contributed to the bind-
ing of collagen XIII to the α11-I domain. The two binding 
sites identified in the COL3 domain of collagen XIII lie 
within a highly conserved region (Fig. 4f).
Homology modeling and structure validation
To study the molecular interaction between the human 
α11-I domain and the triple-helical peptides, a homology 
model of the human α11-I domain was constructed using 
the crystal structure of the human integrin α2-I domain 
(PDB code: 1DZI) (J. Emsley et al. 2000) as a template. 
Prior to the homology model construction, the sequence 
alignment of α11 and α2 integrin I domains were sub-
jected to manual inspection as a quality check; this iden-
tified a shared sequence identity and similarity of 44% 
and 63.1%, respectively (Fig. 5), being amendable for the 
further modeling studies. The energy minimized model 
of the human α11-I domain is shown in Fig. 6a. The root 
mean square deviation between the final energy minimized 
model of the α11-I domain and the α2-I domain was 0.237 
(Fig. 6b), suggesting that the initial backbone structure 
was intact and there was not much deviation from its 
original conformation. Ramachandran plot analysis using 
PROCHECK (Laskowski et al. 1993) showed that 90.1% 
of the residues fall in the most favored regions and 9.3% of 
the residues in the additionally allowed regions (Fig. S2). 
Also, the assessment of the constructed model by its 3D 
profile using VERIFY3D (Eisenberg et al. 1997) showed 
that 100% of the residues are within the allowed regions 
(Fig. S3). Further, the reliability and the quality of the 
model were validated using the ERRAT program (Colovos 
and Yeates 1993). The comparison between the initial 
model (before minimization) and the final model (after 
minimization) showed that the quality of the modeled pro-
tein was significantly increased after minimization with 
the overall quality factor score of 97.093 (Fig. S4). The 
structure validation programs suggest that the constructed 
homology model of the human α11-I domain structure is 
of high quality and reliable, thus, can be used for our dock-
ing studies.
Fig. 2  Adhesion of integrin α11-transfected C2C12 cells to fibronec-
tin and collagens (a) C2C12 control cells and cells transfected with an 
integrin α11cDNA (C2C12-α11+) were seeded on a plastic surface 
coated with fibronectin, collagen I, or the collagen XIII ectodomain. 
The cells were analyzed quantitatively using the β-hexosaminidase 
release assay for the attachment to fibronectin, collagen I, and colla-
gen XIII. Data are presented relative to fibronectin and BSA binding, 
where the saturated binding to fibronectin represents 100% and the 
background binding to a BSA-coated surface represents 0%. Values 
are shown as means of triplicates with standard deviation bars. (b, b’) 
Microscopic monitoring of the attachment and morphology of C2C12 
and C2C12-α11 cells adhering on collagen XIII. Scale bars 200 μm
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Docking of α11‑I domain and triple‑helical collagen 
peptides
To study the collagen XIII binding mode to the α11-I 
domain, we performed docking studies using our homol-
ogy model of α11-I domain and the HADDOCK program 
(Dominguez et al. 2003). First, the interface residues that 
directly interact with the triple-helical collagen were identi-
fied from the crystal structure of the α2-I domain. Then, 
the identified residues were mapped correspondingly to the 
α11-I domain in the sequence alignment. These residues 
were then supplied as active residues of the α11-I domain 
while the passive residues were set to define automatically 
by the HADDOCK program (Dominguez et al. 2003) to per-
form the docking calculations.
The HADDOCK server produced 176 different struc-
tures of the α11-(GPP)2GFQGEK(GPP)3 complex clas-
sified in 8 clusters which represents 88.0% of the water-
refined models. For the α11-(GPP)2GPKGER(GPP)3 
complex, the HADDOCK server resulted in 136 
structures classified in 10 clusters representing 68% 
of the water-refined models. Analysis of the α11-
(GPP)2GFQGEK(GPP)3 complex revealed that the resi-
dues from all the three strands (strands B, C, and D) of the 
collagen peptide contributed to the interactions with the 
interface residues of the α11-I domain (Fig. 7a). Lys12 of 
the strand B, Glu11 and Lys12 of the strand C, and Glu11 
and Lys12 of the strand D were involved in the formation 
of multiple hydrogen bonds with the α11-I domain. Apart 
from the hydrogen bonds, Glu11 and Lys12 of the strand 
Fig. 3  Selective binding of collagen XIII to the integrin α11-I 
domain; a 0.25 μg of collagens I, IV, and XIII in 50 μl of TBS were 
coated on microtiter plates. The GST-α11-I domain was diluted in 
series in TBS containing 30  μg/ml BSA, 2  mM  MgCl2, and 0.05% 
Tween-20 and used for binding tests employing a solid-phase assay 
with an antibody against GST. Five percent of fat-free milk in TBS 
was used for blocking the uncoated surface and for a blank control. b 
A summary of relative binding comparison of I domains to the coated 
collagen types I, IV, and XIII (Col I, Col IV, and Col XIII, respec-
tively). c SPR response of the binding of collagen XIII to the immo-
bilized integrin α11-I domain (black curve). The gray curve shows 
the background of the sensorgram. d A pull-down assay was per-
formed by incubation of collagen XIII with the GST-α11-I domain or 
GST protein coupled glutathione-Sepharose. The interaction complex 
was eluted by 10 mM of reduced glutathione or cleaved by thrombin. 
The eluted, unbound, and unbound incubated overnight (o.n.) colla-
gen XIII was detected by a collagen XIII monoclonal antibody
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C, Lys12 of the strand D also participated in the salt bridge 
formation with the α11-I domain residues. The energy val-
ues of the docked complexes are shown in Table 1 and 
detailed list of hydrogen bonds formed between the atoms 
of α11-I domain and GFQGEK is shown in Table 2.
The interaction between the α11-I domain and 
(GPP)2GPKGER(GPP)3 was distinct compared to the 
(GPP)2GFQGEK(GPP)3 interaction with the α11-I 
domain. Here, much of the interactions come from the 
Lys9 residue of the strand C collagen peptide (Fig. 7b). 
Further, Glu76 of the α11-I domain and Lys9 and Arg12 of 
the collagen peptide from the strand C participated in the 
H-bond and salt bridge formation. Another salt bridge is 
formed between Glu110 of α11-I domain and Lys9 of the 
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strand B. Table 3 shows the detailed list of hydrogen bonds 
and salt-bridges between the acceptor and donor atoms of 
the α11-(GPP)2GPKGER(GPP)3 complex.
Collagen XIII‑integrin α11 interaction regulates 
bone homeostasis in vivo
To study the in  vivo significance of collagen XIII-
α11β1 interaction, we crossbred integrin α11 null 
mice (Itga11−/−) with mice overexpressing Col13a1 
(Col13a1oe (Ylönen et al. 2005, Koivunen et al. 2019)) 
and created a double mutant mouse line (Col13a1oe;I
tga11−/−). The Col13a1oe mice possess a severe bone 
phenotype, in which especially the circumference of 
middiaphyseal femur is enlarged (Koivunen et al. 2019). 
The femoral cortical bone morphology of Col13a1oe and 
Col13a1oe;Itga11−/− mice was evaluated in females at 
five time points and males at four time points by micro-
computed tomography (µCT). As a result, we discovered 
that the Col13a1oe;Itga11−/− double mutant mice had a 
significantly milder bone phenotype when compared to 
Col13a1oe mice, the Col13a1oe;Itga11−/− mice had less 
cortical bone overgrowth (females in Fig. 8a and males 
in Fig. S5a) and the bone loss (females in Fig. 8b and 
males in Fig. S5b) was significantly diminished when 
compared to Col13a1oe. No differences were observed 
in the bone length between these genotypes (females in 
Fig. 8c and males in Fig. S5c). These results indicate 
that collagen XIII-integrin α11β1 interaction has a role 
in cortical bone homeostasis, and this role is evident in 
both genders.
Discussion
Collagens are known to be recognized by the α-I domains 
in collagen receptor integrins α1β1, α2β1, α10β1, and 
α11β1 (Gullberg and Lundgren-Akerlund 2002; Zeltz 
and Gullberg 2016), and it has been shown that α1β1 and 
α10β1 interact preferentially with the basement membrane 
collagen IV and the beaded filament forming collagen VI 
(Tulla et al. 2001; Nykvist et al. 2000), while α11β1 shows 
similar features as α2β1 and selects the interstitial col-
lagens (W. M. Zhang et al. 2003). However, collagen IX, 
a cartilage matrix component, shows exceptionally high 
binding capacity to all four integrin I domains, suggest-
ing a more complicated mechanism for cell adhesion to 
collagens (Käpylä et al. 2004). Here, we show the firm 
interaction of collagen XIII with integrin α11β1.
The motif GFOGER in a triple-helical context has been 
identified as a target sequence for α1β1, α2β1, α10β1, and 
α11β1 integrins (Knight et al. 1998, Xu et al. 2000, W. 
M. Zhang et al. 2003, Sipilä et al. 2014), but these integ-
rins also bind to other ECM proteins that do not contain 
this particular sequence (Pandolfi et al. 2017). On the 
other hand, collagen IV does not bind to α2β1 or α11β1 
as strongly as collagens I–III, although it contains the 
GFOGER sequence in the α1(IV), α3(IV), α4(IV), and 
α5(IV) chains. Additionally, collagen IX, which binds 
avidly to all integrin I domains, lacks the GFOGER 
motif. Hence, it has been proposed that GFOGER is not 
the only target sequence for collagen-binding integrins. 
Indeed, studies on the integrin-recognition motifs in col-
lagen III have identified GROGER, GLKGEN, and GLO-
GEN as integrin-binding sites (Raynal et al. 2006; Kim 
et al. 2005). Moreover, a prokaryotic collagen sequence 
GLPGER has been reported to bind to integrins α2β1 and 
α11β1 (Caswell et al. 2008). A study using the collagen 
peptide ToolKits, which consist of sets of overlapping tri-
ple-helical peptides, identified two motifs GLOGEN and 
GVOGEA that are specific for α1β1 (Hamaia et al. 2012). 
Additional binding motifs identified for collagen-binding 
integrins are GFKGER, GLQGER, GLOGER, and GAS-
GER (Zwolanek et al. 2014; Xu et al. 2000).
Our previous study has shown that the ectodomain of 
the transmembrane collagen XIII binds avidly to the α1-I 
domain (Nykvist et al. 2000). Here, we show that C2C12 
cells expressing α11β1 spread on a collagen XIII-coated 
surface in the same manner as on a collagen I-coated sur-
face. Among the integrin α1-, α2-, and α11-I domains, the 
α11-I domain showed strongest binding to collagen XIII, and 
Fig. 4  Integrin α11 binds to the COL3 domain of collagen XIII 
specifically by GPKGER and GF(S)QGEK. a A solid-phase bind-
ing assay shows binding of the integrin α11-I domain to the COL3 
domain specifically. One hundred nanomolars of the collagen XIII 
ectodomain (Col XIII) and its pepsin-digested collagenous fragments, 
COL1, COL2, and COL3 in 50 μl of HEPES buffer were coated onto 
a microtiter plate wells, and 700  nM of the GST-α11-I domain in 
50 μl of HEPES buffer containing 2 mM  MgCl2 was added for bind-
ing testing. The bound I domain was detected by a GST antibody. b A 
solid-phase binding assay shows binding of the α11-I domain to the 
recombinant proteins composed of the testing motifs flanked by the 
collagenous sequence 5x(GPP) and a foldon sequence at the C-ter-
mini. c, d A cell attachment assay indicates the binding of the specific 
collagen XIII motifs to the integrin α11. GFPGER was used as posi-
tive control. e Cell attachment inhibition by the GPKGER motif. f A 
schematic structure of collagen XIII compiled from previous work 
(Hägg et al. 1998). The black arrowheads indicate the positive bind-
ing sites and the white shows a negative binding site. The grey arrow-
head points to a reported integrin α1-binding site (Dennis J. et  al. 
2010). The numbers above the arrowheads represent the residues in 
the human collagen XIII sequence. The collagenous domains (COL1-
3) are indicated as white boxes, the non-collagenous domains (NC1-
4) as light gray boxes, coiled-coil motifs as dark gray boxes, and the 
transmembrane domain as a black box. The initiation methionine is 
marked as M, cysteine residues as C, and a furin proteolytic cleavage 
site consisting of four arginine residues as (R)4
◂
 Cell and Tissue Research
1 3
the collagen XIII showed more specific interaction with the 
α11-I domain when compared to other collagen types. These 
data suggest differences in the interaction of collagen XIII 
with α11 integrin compared to other α subunits.
Collagen XIII is reported to be a ligand mediating 
integrin α1β1-dependent transmigration of monocytes in 
Alport renal fibrosis (Dennis et al. 2010). In that study, 
α1β1-positive monocytes were shown to bind to a GEK-
GAEGSPGLP sequence located in the COL2 domain of the 
collagen XIII. In the present study, the α11β1 binding site 
in collagen XIII was localized in the COL3 domain. Some 
of the known integrin-binding collagenous motifs, such as 
GFOGER, GLOGER, and GVPGEA (see above), do not 
exist in collagen XIII. Furthermore, we did not consider 
GXXGEN-like sequences (X = any of the amino acid resi-
dues) since these motifs were not preferred in a previous 
study on the α11-I domain utilizing the collagen peptide 
ToolKits (W. M. Zhang et al. 2003). In the present study, 
four motifs, GPKGER, GFQGEK, GSQGEK, and GNRGER 
from the COL3 domain, and GFPGER, used as a positive 
control, were chosen for the binding tests. GNRGER showed 
no binding to the α11, a finding consistent with the ToolKit 
data. GPKGER, GFQGEK, and GSQGEK bound to α11, but 
the interaction was more modest than that with GFPGER. 
Proline hydroxylation is known to be important in collagen-
integrin interaction (Sipilä et al. 2018; Rappu et al. 2019). 
However, in this study, coexpression of prolyl 4-hydroxy-
lase (P4H) in the insect cells did not catalyze the proline 
hydroxylation probably due to the short (GPP)5 sequence, 
which was not sufficient for binding of the enzyme P4H 
to the collagen substrate. Thus, here all prolines are non-
hydroxylated. While many previously reported integrin-
binding motifs contain hydroxyproline (Rappu et al. 2019), 
there are also several exceptions, such as GLSGER and 
GQRGER (Siljander et al. 2004), GFKGER (Zwolanek et al. 
2014), GLQGER (Zwolanek et al. 2014), and GASGER (Xu 
et al. 2000). Moreover, in the hydroxyproline containing 
functional domains hydroxylation of proline residues is not 
absolutely required for integrin binding, but it increases the 
avidity of the interaction. For example, the α2-I domain can 
bind to GFPGER containing peptides, but more weakly than 
to GFOGER (Knight et al. 2000).
To model the interaction between the α11-I domain 
and collagen motifs, two different collagen peptides 
((GPP)2GFQGEK(GPP)3 and (GPP)2GPKGER(GPP)3 
were constructed through in silico approaches. The dock-
ing analysis showed that both constructed triple-helical 
Fig. 5  Sequence alignment. Human integrin α2-I (ITGA2) and α11-I (ITGA11) domains share sequence identity of 43.9% and 63.1%, respec-
tively
Fig. 6  Molecular model of the integrin α11-I domain. a An energy 
minimized structure of human integrin α11-I domain. b A superim-
posed model of the α11-I domain (blue) and the crystal structure of 
human integrin α2-I domain (pink, PDB: 1DZI) is shown. The root 
mean square deviation between these two structures is 0.237
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Fig. 7  Docked complexes 
of collagen tripeptides and 
the α11-I domain. a The 
collagen XIII tripeptide 
(GPP)2GFQGEK(GPP)3 bound 
to the α11-I domain, sidechains 
of the interacting residues are 
labelled and shown on the right 
side. b A complex of α11-
(GPP)2GPKGER(GPP)3 along 
with the interacting residues
Table 1  The best representative docked complex was chosen based 
on the HADDOCK score and the cluster size. Binding energy (ΔG) 
for each of the docked complexes was calculated using the PRODIGY 
server. Van der Waals, electrostatic energy, and buried surface area 
obtained from HADDOCK server are shown
Docked Complex HADDOCK score Binding energy 
ΔG (kcal/mol)





α11-I domain-(GPP)2GFQGEK(GPP)3 − 105.99 ± 9.9 − 6.7 − 41.0 ± 6.1 − 391.4 ± 45.7 1505.4 ± 129.6
α11-I domain-(GPP)2GPKGER(GPP)3 − 60.3 ± 3.4 −7.1 − 30.1.99 ± 4.8 − 290.0 ± 37.0 1109.4 ± 109.2
Table 2  Residues contributing 
to hydrogen bonds between 
the α11-I domain and triple-
helical peptide (GPP)2 
GFQGEK(GPP)3 (chains B, 
C, and D) is shown. The atom 
names and the interacting 
distance (in Angstroms) are 
shown in square brackets
*Involved in salt bridge formation
α11 (GPP)2GFQGEK(GPP)3
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peptides indeed bind to the interface of α11-I domain. In 
the crystal structure of the integrin α2-I domain bound 
to the triple-helical GFOGER peptide (J. Emsley et al. 
2000), the strand C makes most of the interactions with 
the α2-I domain whereas the strand B contributes fewer 
interactions and the strand D makes no interactions as 
it is exposed to the solvent. Consistently, this trend was 
observed in our docking experiments for the GPKGER 
peptide, where most of the hydrogen bonds came from 
the strand C, less hydrogen bonds from the strand B and 
no interaction from the strand D. It can be hypothesized 
that the presence of an arginine (Arg12, the 12th residue 
in the strand C) residue might influence the orientation of 
the triple-helical peptide with the integrin domain such 
that the strand C makes many contacts with the integrin I 
domain similar as seen in the template crystal structure. 
However, for the GFQGEK, most of the hydrogen bonds 
came from the strand C and multiple hydrogen bonds 
were observed from both the strands B and the D. It is 
conceivable that the change of arginine (Arg12) to lysine 
(Lys12) may disrupt the orientation exposing all the three 
strands contacting the I domain. Consequently, our experi-
mental data supports the molecular modeling results as 
C2C12-α11+ cells attach much stronger on GPKGER than 
on GFQGEK (Fig. 4d). Homology modeling and docking 
can be considered a powerful strategy to predict protein-
protein interactions if there is no crystal structure of the 
complexes available (Quignot et al. 2018). Accuracy of 
the docking depends on the quality of the homology model 
(Quignot et al. 2018; Rodrigues et al. 2013); thus, we have 
validated our model at different stages both manually as 
well as using various online servers to obtain a reliable 
prediction of the α11-I domain structure and the docked 
complex (see “Materials and methods”). However, despite 
striving for high-quality predictions in our study, it should 
be noted that the crystal structures of the α11-I domain 
in an unbound and a collagen-bound state remain to be 
solved, allowing further confirmation of our modeling 
results.
The peptide sequence GPKGER exists in 15 different 
collagens (collagens III, IV, V, VII, IX, XI, XIII, XIV, XV, 
XVII, XIX, XX, XXII, XXV, XXVII), while GFQGEK 
exists only in collagens XIII and IV, and GSQGER only 
in mouse collagen XIII and in rat XVII (UniProt Consor-
tium 2019). It is not clear why collagen IV does not bind 
to α11 although it contains both GFOGER and GFQGEK 
sequences (Farndale et al. 2008, W. M. Zhang et al. 2003). 
Collagen IX, which binds to all the four I domains, contains 
the GFKGER sequence also. We propose GFKGER as a new 
general integrin-binding motif, albeit with modest affinity.
In the light of data obtained with cells and mutant mice 
(Hägg et al. 1998, 2001; Kvist et al. 2001; Sund et al. 2001; 
Tahkola et al. 2008; Tuomisto et al. 2008), collagen XIII 
appears to play a role in cell-matrix adhesion. Recent in vivo 
studies highlight involvement of collagen XIII in the devel-
opment, differentiation, and maturation of musculoskel-
etal tissues and vessels and in maintaining tissue integrity 
(Latvanlehto et al. 2010; Härönen et al. 2017; Zainul et al. 
2018; Heikkinen et al. 2019; Koivunen et al. 2019). The 
150-nm flexible ectodomain of collagen XIII can potentially 
cross the basement membrane around myofibrils or under 
endothelium and can penetrate into the surrounding stroma. 
Thus, the in vitro properties of collagen XIII in binding to 
the basement membrane collagen receptor α1β1 and to the 
matrix interstitial collagen receptor α11β1 may be of physi-
ological relevance. Moreover, COL3, the furthest collagen-
ous domain from the plasma membrane, appeared largely 
responsible for the binding to the α11-I domain, suggesting 
that collagen XIII molecules could interact with integrin 
α11β1 molecules occurring in neighboring cells, but this 
aspect was not studied in the present study.
Under physiological conditions, integrin α11β1 is 
expressed in specific subsets of fibroblasts and mesenchy-
mal stem cells (MSCs) (Popov et al. 2011; Shen et al. 2019) 
and it has previously been observed to be up-regulated in 
carcinoma-associated fibroblasts (CAFs) in the tumor stroma 
(Zhu et al. 2007; Smeland et al. 2019). Collagen XIII is 
shown to be up-regulated by TGF-β in the reactive stro-
mal cells of epithelial tumors and throughout mesenchymal 
tumors. The induction of collagen XIII expression occurs at 
an early stage in tumor progression in response to malignant 
transformation (Väisänen et al. 2005).
Integrin α11β1 is a regulator of MSC survival on collagen I 
(Popov et al. 2011). Moreover, α11β1 is found in leptin receptor 
positive MSCs in the bone marrow where α11β1 has shown to 
Table 3   Residues contributing to hydrogen bonds between the α11-I 
domain and triple-helical peptide (GPP)2GPKGER(GPP)3 (chains 
B and C) is shown. The atom names and the interacting distance (in 
Angstroms) are shown in square brackets
*Involved in salt bridge formation
α11 (GPP)2GPKGER(GPP)3
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be an osteolectin receptor and a regulator of osteogenesis and 
bone homeostasis (Shen et al. 2019). Conditional deletion of 
the α11 subunit from leptin receptor positive bone marrow cells 
accelerates trabecular bone loss in aged mice without alterations 
to body size, femoral length or cortical bone area. However, the 
mineral apposition rate is significantly reduced in cortical bone 
in these mice compared to littermate controls. We have previ-
ously shown that collagen XIII regulates bone remodeling and 
angiogenesis through β1 integrins (Koivunen et al. 2019). The 
novel double mutant mouse line presented here, Col13a1oe;I
tga11−/−, has a milder high bone mass phenotype compared to 
Col13a1oe mice. More specifically, double mutants have signifi-
cantly less bone overgrowth and milder osteoporosis compared 
to Col13a1oe mice. A comparable phenotype was seen in both 
sexes up to 35 weeks of age. We were not, however, able to 
complete a full cohort of the male mice to the final time point on 
account of insufficient amount of mice available for the experi-
ment. These data suggest that collagen XIII-triggered effects in 
Fig. 8  Collagen XIII-integrin 
α11 interaction affects bone 
homeostasis. µCT results of 
cortical bone area (Ct.Ar.) 
a and cortical thickness (Ct.
Th.) b. No difference was seen 
in the length of the femurs 
c. Number of mice analyzed 
in order of increasing age: 
female Col13a1oe (7, 4, 6, 6, 
6), female Col13a1oe;Itga11−/− 
(3, 3, 4, 3, 2). **q < 0.01 and 
***q < 0.001 determined by 
two-way ANOVA followed by 
FDR
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bone homeostasis may be mediated by α11β1. However, Itga11 
deficiency does not lead to full rescue of the bone phenotype 
indicating existence of other, unknown, mechanisms triggered 
by collagen XIII.
In conclusion, we identify integrin α11 as a new collagen 
XIII receptor and show that this ligand/receptor pair may 
have a role in bone homeostasis. Additionally, we propose 
GFKGER as a new general integrin-binding motif with mod-
erate affinity.
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